Chronic Lymphocytic Leukemia Research
Moving in Blood, Gastroenterology, bioRxiv, medRxiv and Nature Communications.
- Moved, week to 23 Oct 2026
- 0
- Papers in 60 days
- 10
Rebuilt
Moved this week
Nothing in this topic has moved yet this week.
Latest in Chronic Lymphocytic Leukemia Research
Newest first · last 60 days
Roginolisib selectively inhibits PI3Kδ by stabilizing the C-terminal helix kα12, locking the enzyme in an inactive conformation.
- Open access
- 1 cites
In PTPN11-mutant juvenile myelomonocytic leukemia, dual NLRP3 and PTGS2 inhibition combined with MEK blockade significantly prolongs survival and reduces leukemic burden in models.
- Open access
IL-16-driven signaling mediates resistance to BTK inhibitors and R-CHOP in B-cell lymphomas, with IL-16 upregulation observed in resistant cases.
- Open access
- 6 cites
Ibrutinib improves event-free survival in early-stage CLL patients with certain genetic mutations but offers no overall survival benefit across all subgroups.
Browse JClub
Journals this month
- bioRxiv6157
- medRxiv1716
- PNAS447
- Sci Adv354
- JAMA262
- Environ Res230
- BMJ182
- Environ Pollution165
- Nat Commun161
- Science141
- Nature138
- Lancet128
- Cell Rep120
- NEJM119
- mBio107
- Plant Cell Environ107
- Curr Biol106
- J Exp Bot106
Topics moving, week to 23 Oct 2026
- Single-cell and spatial transcriptomics6
- Neuroinflammation and Neurodegeneration Mechanisms5
- Bacteriophages and microbial interactions5
- Gut microbiota and health5
- Genomics and Phylogenetic Studies4
- Cancer Genomics and Diagnostics4
- Cancer Immunotherapy and Biomarkers4
- Alzheimer's disease research and treatments3
- Inflammatory Bowel Disease3
- Influenza Virus Research Studies3
